Sun protection: a practical guide for health professionals.

IF 4.3 Q2 PHARMACOLOGY & PHARMACY
Samuel Morriss, Laura Scardamaglia
{"title":"Sun protection: a practical guide for health professionals.","authors":"Samuel Morriss, Laura Scardamaglia","doi":"10.18773/austprescr.2025.046","DOIUrl":null,"url":null,"abstract":"<p><p>Cumulative exposure to ultraviolet radiation drives skin cancer and photo-ageing across all skin types, including people with darker skin. Visible light radiation plays a key role in the pathogenesis of pigmentary conditions. Intense childhood exposure to ultraviolet radiation is a critical risk factor for development of melanoma later in life. Effective sun protection requires a daily, multifaceted approach when the ultraviolet index is 3 or higher. This includes the correct application of broad-spectrum sunscreen with a sun protection factor of 50+ in conjunction with protective clothing, a broad-brimmed hat, sunglasses, and seeking shade. Some medicines may be photosensitising and patients using these medicines should be advised to adopt stricter sun protection measures. There are many myths about sunscreens that may be barriers to sunscreen use, including concerns about endocrine disruption and nanoparticle toxicity. When counselling patients on sun protection, it is important to offer practical, evidence-based advice that extends beyond sunscreen use alone. The goal is to empower patients to incorporate sun safety into their daily routines.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 5","pages":"173-178"},"PeriodicalIF":4.3000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12566446/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18773/austprescr.2025.046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Cumulative exposure to ultraviolet radiation drives skin cancer and photo-ageing across all skin types, including people with darker skin. Visible light radiation plays a key role in the pathogenesis of pigmentary conditions. Intense childhood exposure to ultraviolet radiation is a critical risk factor for development of melanoma later in life. Effective sun protection requires a daily, multifaceted approach when the ultraviolet index is 3 or higher. This includes the correct application of broad-spectrum sunscreen with a sun protection factor of 50+ in conjunction with protective clothing, a broad-brimmed hat, sunglasses, and seeking shade. Some medicines may be photosensitising and patients using these medicines should be advised to adopt stricter sun protection measures. There are many myths about sunscreens that may be barriers to sunscreen use, including concerns about endocrine disruption and nanoparticle toxicity. When counselling patients on sun protection, it is important to offer practical, evidence-based advice that extends beyond sunscreen use alone. The goal is to empower patients to incorporate sun safety into their daily routines.

防晒:健康专业人士实用指南。
长期暴露在紫外线辐射下会导致所有皮肤类型的皮肤癌和光老化,包括皮肤较黑的人。可见光辐射在色素疾病的发病机制中起着关键作用。儿童时期强烈暴露于紫外线辐射是日后患黑色素瘤的关键风险因素。当紫外线指数为3或更高时,有效的防晒需要每天采取多方面的措施。这包括正确使用防晒系数为50+的广谱防晒霜,并搭配防护服、宽边帽、太阳镜和寻找阴凉处。有些药物可能具有光敏性,应建议使用这些药物的患者采取更严格的防晒措施。关于防晒霜的许多误解可能是使用防晒霜的障碍,包括对内分泌干扰和纳米颗粒毒性的担忧。在向患者提供防晒咨询时,重要的是提供实用的、基于证据的建议,而不仅仅是防晒霜的使用。这样做的目的是让患者在日常生活中注意防晒。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Australian Prescriber
Australian Prescriber MEDICINE, GENERAL & INTERNAL-PHARMACOLOGY & PHARMACY
CiteScore
3.80
自引率
7.40%
发文量
71
审稿时长
>12 weeks
期刊介绍: Australian Prescriber is Australia''s free, national, independent journal of drugs and therapeutics. It is published every two months online. Our purpose is to help health professionals make informed choices when prescribing, including whether to prescribe a drug or not. To do this we provide independent, reliable and accessible information. As well as publishing short didactic reviews, we facilitate debate about complex, controversial or uncertain therapeutic areas. We are part of NPS MedicineWise, an independent, non-profit organisation providing medicines information and resources for health professionals, and stakeholders involved in the quality use of medicines. NPS MedicineWise is funded by the Australian Government Department of Health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书